Angelika Holler

1.0k total citations
26 papers, 752 citations indexed

About

Angelika Holler is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Angelika Holler has authored 26 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 22 papers in Immunology and 5 papers in Genetics. Recurrent topics in Angelika Holler's work include CAR-T cell therapy research (20 papers), Immune Cell Function and Interaction (17 papers) and Immunotherapy and Immune Responses (16 papers). Angelika Holler is often cited by papers focused on CAR-T cell therapy research (20 papers), Immune Cell Function and Interaction (17 papers) and Immunotherapy and Immune Responses (16 papers). Angelika Holler collaborates with scholars based in United Kingdom, Germany and Netherlands. Angelika Holler's co-authors include Hans J. Stauss, Shao‐An Xue, Graham P. Wright, Gavin Bendle, Emma Morris, Clare A. Notley, Ton N. Schumacher, Michael R. Ehrenstein, Sharyn Thomas and Maryam Ahmadi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Angelika Holler

26 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelika Holler United Kingdom 16 514 495 179 164 60 26 752
Uxua Mancheño Spain 14 343 0.7× 350 0.7× 192 1.1× 164 1.0× 38 0.6× 19 623
Tania C. Felizardo United States 12 362 0.7× 592 1.2× 167 0.9× 66 0.4× 89 1.5× 23 911
Jonathan Fisher United Kingdom 14 648 1.3× 597 1.2× 150 0.8× 129 0.8× 51 0.8× 30 961
Monika Laumer Germany 8 414 0.8× 596 1.2× 116 0.6× 94 0.6× 54 0.9× 9 714
Jean‐Christophe Beltra United States 8 595 1.2× 737 1.5× 195 1.1× 47 0.3× 52 0.9× 9 962
Samuel Alsén Sweden 9 277 0.5× 513 1.0× 191 1.1× 56 0.3× 43 0.7× 15 737
Romy E. Hoeppli Canada 10 352 0.7× 588 1.2× 100 0.6× 92 0.6× 51 0.8× 17 786
Elien M. Doorduijn Netherlands 10 496 1.0× 663 1.3× 222 1.2× 51 0.3× 41 0.7× 12 867
Leticia Barba Switzerland 6 643 1.3× 676 1.4× 150 0.8× 42 0.3× 30 0.5× 6 890
Silvia Lorenzi Italy 7 341 0.7× 482 1.0× 180 1.0× 39 0.2× 80 1.3× 8 702

Countries citing papers authored by Angelika Holler

Since Specialization
Citations

This map shows the geographic impact of Angelika Holler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelika Holler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelika Holler more than expected).

Fields of papers citing papers by Angelika Holler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelika Holler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelika Holler. The network helps show where Angelika Holler may publish in the future.

Co-authorship network of co-authors of Angelika Holler

This figure shows the co-authorship network connecting the top 25 collaborators of Angelika Holler. A scholar is included among the top collaborators of Angelika Holler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelika Holler. Angelika Holler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Sharyn, et al.. (2024). Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function. Frontiers in Immunology. 15. 1386132–1386132. 1 indexed citations
2.
Holler, Angelika, et al.. (2022). Forced Fox-P3 expression can improve the safety and antigen-specific function of engineered regulatory T cells. Journal of Autoimmunity. 132. 102888–102888. 15 indexed citations
3.
Deng, Yun, Bithi Chatterjee, Kyra D. Zens, et al.. (2021). CD27 is required for protective lytic EBV antigen–specific CD8+ T-cell expansion. Blood. 137(23). 3225–3236. 27 indexed citations
4.
Chatterjee, Bithi, Yun Deng, Angelika Holler, et al.. (2019). CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo. PLoS Pathogens. 15(5). e1007748–e1007748. 56 indexed citations
5.
Thomas, Sharyn, Fiyaz Mohammed, Rogier M. Reijmers, et al.. (2019). Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function. Nature Communications. 10(1). 4451–4451. 43 indexed citations
6.
Hotblack, Alastair, Angelika Holler, Alice Piapi, et al.. (2018). Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma. Molecular Therapy. 26(6). 1471–1481. 15 indexed citations
7.
Alsaieedi, Ahdab, Angelika Holler, Pedro Veliça, Gavin Bendle, & Hans J. Stauss. (2018). Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells. OncoImmunology. 8(3). 1542917–1542917. 28 indexed citations
8.
Holler, Angelika, Sara Ghorashian, Alastair Hotblack, et al.. (2016). Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy. Haematologica. 101(4). 482–490. 2 indexed citations
9.
Veliça, Pedro, Siân M. Henson, Angelika Holler, et al.. (2015). Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory Formation. Cancer Research. 75(13). 2641–2652. 19 indexed citations
10.
Xue, Shao‐An, Liquan Gao, Maryam Ahmadi, et al.. (2012). Human MHC Class I-restricted high avidity CD4+T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo. OncoImmunology. 2(1). e22590–e22590. 35 indexed citations
11.
Pospori, Constandina, Shao‐An Xue, Angelika Holler, et al.. (2011). Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination. Blood. 117(25). 6813–6824. 16 indexed citations
12.
Wright, Graham P., Clare A. Notley, Shao‐An Xue, et al.. (2009). Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Proceedings of the National Academy of Sciences. 106(45). 19078–19083. 177 indexed citations
13.
Xue, Shao‐An, Gavin Bendle, Angelika Holler, & Hans J. Stauss. (2008). Generation and characterization of transgenic mice expressing a T‐cell receptor specific for the tumour‐associated antigen MDM2. Immunology. 124(3). 315–321. 2 indexed citations
14.
Indra, A., Steliana Huhulescu, G. Feierl, et al.. (2008). First cases of Clostridium difficile PCR ribotype 027 acquired in Austria. Eurosurveillance. 13(20). 5 indexed citations
15.
Bendle, Gavin, Shao‐An Xue, Angelika Holler, & Hans J. Stauss. (2007). A Study of T Cell Tolerance to the Tumor-Associated Antigen MDM2: Cytokines Can Restore Antigen Responsiveness, but Not High Avidity T Cell Function. PLoS ONE. 2(4). e353–e353. 7 indexed citations
16.
McNicol, Anne‐Marie, Gavin Bendle, Angelika Holler, et al.. (2007). CD8α/α homodimers fail to function as co‐receptor for a CD8‐dependent TCR. European Journal of Immunology. 37(6). 1634–1641. 25 indexed citations
17.
Stauss, Hans J., Michela Cesco-Gaspere, Sharyn Thomas, et al.. (2007). Monoclonal T-Cell Receptors: New Reagents for Cancer Therapy. Molecular Therapy. 15(10). 1744–1750. 40 indexed citations
18.
Stauss, Hans J., Sharyn Thomas, Michela Cesco-Gaspere, et al.. (2007). WT1-specific T cell receptor gene therapy: Improving TCR function in transduced T cells. Blood Cells Molecules and Diseases. 40(1). 113–116. 43 indexed citations
19.
Gillmore, Roopinder, Shao‐An Xue, Angelika Holler, et al.. (2006). Detection of Wilms' Tumor Antigen–Specific CTL in Tumor-Draining Lymph Nodes of Patients with Early Breast Cancer. Clinical Cancer Research. 12(1). 34–42. 35 indexed citations
20.
Bendle, Gavin, et al.. (2005). Broadly expressed tumour?associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy. Expert Opinion on Biological Therapy. 5(9). 1183–1192. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uxua Mancheño Breakdown of academic impact, for papers by Tania C. Felizardo Breakdown of academic impact, for papers by Jonathan Fisher Breakdown of academic impact, for papers by Monika Laumer Breakdown of academic impact, for papers by Jean‐Christophe Beltra Breakdown of academic impact, for papers by Samuel Alsén Breakdown of academic impact, for papers by Romy E. Hoeppli Breakdown of academic impact, for papers by Elien M. Doorduijn Breakdown of academic impact, for papers by Leticia Barba Breakdown of academic impact, for papers by Silvia Lorenzi
Rankless by CCL
2026